United States - English - NLM (National Library of Medicine)

med-pharmex, inc - ceftiofur sodium (unii: nhi34is56e) (ceftiofur - unii:83jl932i1c) - ceftiofur sodium 50 mg in 1 ml - cattle ceftiofur sodium sterile powder is indicated for treatment of bovine respiratory disease (shipping fever, pneumonia) associated with mannheimia haemolytica , pasteurella multocida and histophilus somni . ceftiofur sodium sterile powder is also indicated for treatment of acute bovine interdigital necrobacillosis (foot rot, pododermatitis) associated with fusobacterium necrophorum and bacteroides melaninogenicus . swine ceftiofur sodium sterile powder is indicated for treatment/control of swine bacterial respiratory disease (swine bacterial pneumonia) associated with actinobacillus (haemophilus) pleuropneumoniae , pasteurella multocida , salmonella choleraesuis and streptococcus suis . sheep ceftiofur sodium sterile powder is indicated for treatment of sheep respiratory disease (sheep pneumonia) associated with mannheimia haemolytica and pasteurella multocida . goat ceftiofur sodium sterile powder is indicated for treatment of caprine respiratory disease (goat pneumonia) associated with mannheimia ha

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - ceftiofur as ceftiofur hydrochloride - unknown - ceftiofur as ceftiofur hydrochloride antibiotic active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - ceftiofur hydrochloride - unknown - ceftiofur hydrochloride antibiotic active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zamira life sciences pty ltd - ceftiofur as ceftiofur sodium - unknown - ceftiofur as ceftiofur sodium antibiotic active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - ceftiofur as ceftiofur hydrochloride - unknown - ceftiofur as ceftiofur hydrochloride antibiotic active 0.0 - active constituent

United States - English - NLM (National Library of Medicine)

zoetis inc. - ceftiofur (unii: 83jl932i1c) (ceftiofur - unii:83jl932i1c) - ceftiofur 200 mg in 1 ml - excede sterile suspension is indicated for treatment of bovine respiratory disease (brd, shipping fever, pneumonia) associated with mannheimia haemolytica , pasteurella multocida, and histophilus somni in beef, non-lactating dairy, and lactating dairy cattle. excede sterile suspension is also indicated for the control of respiratory disease in beef and non-lactating dairy cattle which are at high risk of developing brd associated with m. haemolytica , p. multocida, and h. somni . excede sterile suspension is also indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with fusobacterium necrophorum and porphyromonas levii in beef, non-lactating dairy, and lactating dairy cattle. excede sterile suspension is also indicated for treatment of acute metritis (0-10 days post-partum) associated with bacterial organisms susceptible to ceftiofur in lactating dairy cattle. as with all drugs, the use of excede sterile suspension is contraindicated in animals previously found to be hypersensitive to the drug. excede sterile suspension is contraindicated in horses with known allergy to ceftiofur or to ß-lactam (penicillins and cephalosporins) group antimicrobials. due to the extended exposure in horses, based on the drug's pharmacokinetic properties, adverse reactions may require prolonged care.

United States - English - NLM (National Library of Medicine)

zoetis inc. - ceftiofur hydrochloride (unii: 6822a07436) (ceftiofur - unii:83jl932i1c) - ceftiofur 500 mg in 10 ml - spectramast® dc ceftiofur hydrochloride sterile suspension is indicated for the treatment of subclinical mastitis in dairy cattle at the time of dry off associated with staphylococcus aureus , streptococcus dysgalactiae , and streptococcus uberis . spectramast® dc ceftiofur hydrochloride sterile suspension has been proven effective against staphylococcus aureus , streptococcus dysgalactiae , and streptococcus uberis . as with all drugs, the use of spectramast® dc sterile suspension is contraindicated in animals previously found to be hypersensitive to the drug.

United States - English - NLM (National Library of Medicine)

zoetis inc. - ceftiofur hydrochloride (unii: 6822a07436) (ceftiofur - unii:83jl932i1c) - ceftiofur 125 mg in 10 ml - spectramast® lc (ceftiofur intramammary suspension) sterile suspension is indicated for use in lactating dairy cattle for (1) the treatment of clinical mastitis associated with coagulase-negative staphylococci, streptococcus dysgalactiae , and escherichia coli and (2) the treatment of diagnosed subclinical mastitis associated with coagulase-negative staphylococci and streptococcus dysgalactiae . as with all drugs, the use of spectramast® lc sterile suspension is contraindicated in animals previously found to be hypersensitive to the drug.

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - ceftiofur sodium (unii: nhi34is56e) (ceftiofur - unii:83jl932i1c) - ceftiofur sodium 990 g in 1000 g

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - ceftiofur sodium (unii: nhi34is56e) (ceftiofur - unii:83jl932i1c) - ceftiofur 495 g in 500 g